Simplex Trading
EW icon

Simplex Trading’s Edwards Lifesciences EW Stock Holding History

Simplex Trading’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$697K Sell
8,700
-51,400
-86% -$4.24M ﹤0.01% 2887
2025
Q4 		$5.12M Sell
60,100
-14,700
-20% -$1.21M ﹤0.01% 1243
2025
Q3 		$5.82M Sell
74,800
-61,300
-45% -$4.79M ﹤0.01% 1328
2025
Q2 		$10.6M Buy
136,100
+39,800
+41% +$2.97M 0.01% 850
2025
Q1 		$6.98M Sell
96,300
-51,000
-35% -$3.65M ﹤0.01% 1095
2024
Q4 		$10.9M Buy
147,300
+17,000
+13% +$1.19M 0.01% 973
2024
Q3 		$8.6M Sell
130,300
-10,100
-7% -$734K 0.01% 1133
2024
Q2 		$13M Sell
140,400
-322,200
-70% -$28.5M 0.01% 857
2024
Q1 		$44.2M Buy
462,600
+46,700
+11% +$3.92M 0.03% 372
2023
Q4 		$31.7M Buy
415,900
+190,500
+85% +$13.3M 0.02% 506
2023
Q3 		$15.6M Buy
225,400
+160,100
+245% +$12.9M 0.01% 704
2023
Q2 		$6.16M Sell
65,300
-25,000
-28% -$2.17M 0.01% 1180
2023
Q1 		$7.47M Sell
90,300
-46,000
-34% -$3.62M 0.01% 1055
2022
Q4 		$10.2M Buy
136,300
+35,500
+35% +$2.74M 0.01% 839
2022
Q3 		$8.33M Buy
100,800
+71,800
+248% +$6.91M 0.01% 884
2022
Q2 		$2.76M Sell
29,000
-18,600
-39% -$1.93M ﹤0.01% 1582
2022
Q1 		$5.6M Sell
47,600
-2,800
-6% -$314K 0.01% 1162
2021
Q4 		$6.53M Buy
50,400
+2,200
+5% +$257K 0.01% 1040
2021
Q3 		$5.05M Hold
48,200
– – ﹤0.01% 1201
2021
Q2 		$4.99M Buy
48,200
+47,910
+16,521% +$4.52M ﹤0.01% 1196
2021
Q1 		$2.42M Buy
+290
New +$24.5K ﹤0.01% 1413
2020
Q4 		– Sell
-975
Closed -$7.78M – 8531
2020
Q3 		$7.78M Buy
975
+366
+60% +$28.6K 0.01% 627
2020
Q2 		$4.21M Buy
609
+12
+2% +$853 0.01% 961
2020
Q1 		$3.75M Buy
597
+174
+41% +$12.5K 0.01% 857
2019
Q4 		$3.29M Sell
423
-750
-64% -$58.6K 0.01% 1083
2019
Q3 		$8.6M Buy
1,173
+966
+467% +$67.9K 0.02% 471
2019
Q2 		$1.27M Sell
207
-1,518
-88% -$91.8K ﹤0.01% 1691
2019
Q1 		$11M Buy
1,725
+999
+138% +$57K 0.03% 362
2018
Q4 		$3.71M Sell
726
-1,704
-70% -$86.2K 0.01% 716
2018
Q3 		$14.1M Buy
2,430
+1,323
+120% +$64.7K 0.05% 271
2018
Q2 		$5.37M Buy
1,107
+846
+324% +$39.5K 0.02% 543
2018
Q1 		$17K Sell
261
-117
-31% -$5.08K ﹤0.01% 3501
2017
Q4 		$18K Sell
378
-231
-38% -$8.48K ﹤0.01% 3383
2017
Q3 		$54K Buy
609
+99
+19% +$3.78K ﹤0.01% 2228
2017
Q2 		$44K Sell
510
-585
-53% -$21.4K ﹤0.01% 2505
2017
Q1 		$166K Buy
1,095
+480
+78% +$15K 0.01% 1354
2016
Q4 		$210K Buy
615
+237
+63% +$7.68K 0.01% 1021
2016
Q3 		$35K Sell
378
-36
-9% -$1.36K ﹤0.01% 2423
2016
Q2 		$23K Sell
414
-150
-27% -$5.13K ﹤0.01% 2773
2016
Q1 		$37K Buy
564
+165
+41% +$4.55K ﹤0.01% 2228
2015
Q4 		$9K Sell
399
-129
-24% -$3.35K ﹤0.01% 3384
2015
Q3 		$70K Buy
528
+180
+52% +$4.34K 0.01% 1713
2015
Q2 		$16K Sell
348
-18
-5% -$406 ﹤0.01% 2657
2015
Q1 		$11K Buy
366
+186
+103% +$4.17K ﹤0.01% 2861
2014
Q4 		$4K Buy
+180
New +$3.62K ﹤0.01% 3234

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Simplex Trading's EW Position: Q3 2025 in Review

Simplex Trading sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 9,510 shares — an estimated $743K sold.

Simplex Trading first reported a position in EW in Q4 2014 and held it in 25 quarters. The position peaked at $6.12M in Q1 2024. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Simplex Trading reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 9,510 Edwards Lifesciences shares in Q3 2025, an estimated $743K.
  • Simplex Trading first reported a position in Edwards Lifesciences in Q4 2014 and held it in 25 quarters.
  • Simplex Trading's Edwards Lifesciences position peaked at $6.12M in Q1 2024.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.